Search research articles
Contact Us
Filters
Showing results (31-40 of 118) with videos related to
Page
of 12
Sort By:
Seminars in Nephrology
|
September 1, 1991
Antihypertensive therapy and the progression of chronic renal disease. Are there renoprotective drugs?
J P Tolins, L Raij
Kidney International. Supplement
|
November 1, 1990
Angiotensin converting enzyme inhibitors and progression of chronic renal failure
J P Tolins, L Raij
Journal of the American Society of Nephrology : JASN
|
February 1, 1993
Endothelium-derived relaxing factor, nitric oxide: effects on and production by mesangial cells and the glomerulus
L Raij, P J Shultz
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1988
Adverse effect of amphotericin B administration on renal hemodynamics in the rat. Neurohumoral mechanisms and influence of calcium channel blockade
J P Tolins, L Raij
American Journal of Hypertension
|
December 1, 1992
Effect of amlodipine on mesangial cell proliferation and protein synthesis
P J Shultz, L Raij
Contributions to Nephrology
|
January 1, 1995
Pathophysiology of the interaction between mesangium and endothelium
D del Castillo, L Raij
Archives of Internal Medicine
|
November 8, 1993
Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy
N K Hollenberg, L Raij
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 1, 1991
The glomerular mesangium: role in initiation and progression of renal injury
P J Shultz, L Raij
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 1, 1985
Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules
W F Keane, L Raij
Current Hypertension Reports
|
September 12, 2000
Postmenopausal hypertension
L M Harrison-Bernard, L Raij
Page
of 12
Search research articles
Search
Showing results (31-40 of 118) with videos related to
Sort By:
Page
of 12
Seminars in Nephrology
|
September 1, 1991
Antihypertensive therapy and the progression of chronic renal disease. Are there renoprotective drugs?
J P Tolins, L Raij
Kidney International. Supplement
|
November 1, 1990
Angiotensin converting enzyme inhibitors and progression of chronic renal failure
J P Tolins, L Raij
Journal of the American Society of Nephrology : JASN
|
February 1, 1993
Endothelium-derived relaxing factor, nitric oxide: effects on and production by mesangial cells and the glomerulus
L Raij, P J Shultz
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1988
Adverse effect of amphotericin B administration on renal hemodynamics in the rat. Neurohumoral mechanisms and influence of calcium channel blockade
J P Tolins, L Raij
American Journal of Hypertension
|
December 1, 1992
Effect of amlodipine on mesangial cell proliferation and protein synthesis
P J Shultz, L Raij
Contributions to Nephrology
|
January 1, 1995
Pathophysiology of the interaction between mesangium and endothelium
D del Castillo, L Raij
Archives of Internal Medicine
|
November 8, 1993
Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy
N K Hollenberg, L Raij
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 1, 1991
The glomerular mesangium: role in initiation and progression of renal injury
P J Shultz, L Raij
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 1, 1985
Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules
W F Keane, L Raij
Current Hypertension Reports
|
September 12, 2000
Postmenopausal hypertension
L M Harrison-Bernard, L Raij
Page
of 12